ArticleScientific reports2026
Comparison of clinical and inflammatory markers for dry eye disease following phacoemulsification and manual small incision cataract surgery (MSICS).
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Differential Characteristics, Mechanisms, and Clinical Strategies for Perioperative Dry Eye in Presenile Cataract and Age-Related Cataract.Healthcare (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We compared clinical and inflammatory markers in patients undergoing cataract surgery by phacoemulsification and manual small incision cataract surgery (MSICS) in 86 patients (43: MSICS, 43: phacoemulsification), 40 years or older, with uncomplicated cataracts. Dry eye evaluation was done preoperatively and on days 1, 21, and 60 after surgery by Ocular Surface Disease Index (OSDI) questionnaire, Schirmer's I test, tear film break-up time (TBUT), and National Eye Institute (NEI) ocular staining score; meibomian gland dysfunction (MGD) assessed using the Lid Margin Score (LMS) and Meibum quality score (MQS); tear fluid interleukins (IL), IL -1β and IL-6. The OSDI, Schirmer I, TBUT, and NEI OSS were significantly worse on post-op Day 1 and improved by Day 60; TBUT was significantly lower in the MSICS than in the phacoemulsification group at all post-op visits. Both groups had mild MGD that improved post-operatively, but MQS was significantly worse in the phacoemulsification group. IL-1β and IL-6 levels were higher on post-op Day 1, returning to near baseline levels by Day 60. We found that MSICS and phacoemulsification have acute detrimental effects on the ocular surface, as evidenced by clinical and inflammatory markers, with TBUT being considerably worse in the MSICS group and MGD being worse in the phacoemulsification group.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.